Zealand Pharma A/s Stock
Zealand Pharma A/s Stock
Pros and Cons of Zealand Pharma A/s in the next few years
Pros
Cons
Performance of Zealand Pharma A/s vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Zealand Pharma A/s | 1.670% | -12.133% | -12.711% | -42.903% | -36.906% | 123.862% | - |
| Saniona AB | -2.560% | 5.400% | 47.744% | 215.217% | 190.831% | 731.967% | -6.452% |
| Actinium Pharmaceuticals Inc. | 0.210% | 14.078% | 12.261% | 20.719% | 22.502% | -86.481% | -85.079% |
| NanoViricides Inc. | -4.630% | -6.087% | -10.000% | -22.857% | -28.000% | -7.256% | -62.500% |
News
New APAC Partnership with Matter Brings Market Logic Software's Always-On Insights Solutions to Local Brand and Experience Leaders
BERLIN, DE / ACCESS Newswire / December 16, 2025 / Market Logic Software, the market-leading SaaS provider of insight management solutions, has announced a partnership with Matter, a New
Why Rocket Lab Stock Keeps Going Up
Rocket Lab (NASDAQ: RKLB) stock rocketed to a 10th straight day of gains Friday, surging 5.7% through 11:15 a.m. ET after announcing the New Zealand-based space company announced yet another big
Cantor Boosts Rocket Lab Target to Street-High $35
Aerospace and defense corporation Rocket Lab USA (NASDAQ: RKLB) recently received a significant analyst boost when Cantor Fitzgerald increased its target price for the space company to a


